Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...
A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...
A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...
Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis.
A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...
Dr. Jeff Watson, with Dynamic Spine and Neuropathy in Sioux Falls, is a leading expert in the field of chiropractics. He recently released a groundbreaking new book titled “A Patient’s ...
The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...
Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...
Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...
The study was conducted at the Federal University of São Paulo and involved 144 diabetic patients, who were treated with ...